---
$id: https://graph.org.ai/products/commodity/51192006
$type: Product
source: UNSPSC
code: "51192006"
title: "Neocinchophen"
class: "51192000"
classTitle: "Antigout drugs"
family: "51190000"
familyTitle: "Agents affecting water and electrolytes"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neocinchophen

**UNSPSC Code**: 51192006
**Class**: [Antigout drugs](Antigout drugs.mdx)
**Family**: [Agents affecting water and electrolytes](../Agents affecting water and electrolytes.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a uricosuric agent and analgesic agent with the molecular formula C19H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 539M941Y9O, chemically known as 6-methylcinchophen, ethyl ester but generally known as neocinchophen, which bears US NIH Compound Identifier 68089. European Medicines Agency schedules Neocinchophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09194MIG. The term NEOCINCHOPHEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). NEOCINCHOPHEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule neocinchophen under HS 29334910 and SITC 51575. As of Q4 2014, NEOCINCHOPHEN remains the US FDA Preferred Term for this commodity. Neocinchophen bears US NLM identifiers UMLS ID C0301393 and NCI Concept Code C75068. SMILES: O(C(=O)C1C2C(NC(C1)C1CCCCC1)CCC(C2)C)CC.

